Abstract: Aim: To validate a method for determining equivalent drug cutoff concentrations for tetrahydrocannabinol and amphetamine in blood and oral fluid, which ensures that the drug prevalence in samples of blood and oral fluid taken simultaneously is equal. Methods: A method using regression analysis of drug concentrations for defined percentiles in blood and oral fluid was developed. The accuracy and precision of this technique was investigated. As study populations, 311 cannabis users and 197 amphetamine users from the Rosita--2 Project were used. Results: A total of 80 paired oral fluid and blood concentrations were needed to determine accurate regression formulae. When using the formulae to calculate drug cutoff concentrations in oral fluid corresponding to 2.0, 4.0, 6.0, 8.0 and 10.0 ng/ml tetrahydrocannabinol in blood and 200, 400, 600, 800 and 1000 ng/ml amphetamine in blood, the accuracy was better than 100±20% compared to actual prevalence in blood with precision better than ±20%. Conclusion: Prevalence regression may be a useful tool in estimating equivalent cutoff concentrations in blood and oral fluid. Methods: A method using regression analysis of drug concentrations for defined percentiles in blood and oral fluid was developed. The accuracy and precision of this technique was investigated. As study populations, 311 cannabis users and 197 amphetamine users from the Rosita-2 Project were used.
Estimating equivalent cutoff thresholds for drugs in blood
and oral fluid using prevalence regression: A study of tetrahydrocannabinol and amphetamine
A B S T R A C T
Aim: To validate a method for determining equivalent drug cutoff concentrations for tetrahydrocannabinol and amphetamine in blood and oral fluid, which ensures that the drug prevalence in samples of blood and oral fluid taken simultaneously is equal.
Methods:
A method using regression analysis of drug concentrations for defined percentiles in blood and oral fluid was developed. The accuracy and precision of this technique was investigated. As study populations, 311 cannabis users and 197 amphetamine users from the Rosita-2 Project were used.
Results: A total of 80 paired oral fluid and blood concentrations were needed to determine accurate regression formulae. When using the formulae to calculate drug cutoff concentrations in oral fluid corresponding to 2.0, 4.0, 6.0, 8.0 and 10.0 ng/ml tetrahydrocannabinol in blood and 200, 400, 600, 800 and 1000 ng/ml amphetamine in blood, the accuracy was better than 100±20% compared to actual prevalence in blood with precision better than ±20%.
Introduction
The collection and analysis of oral fluid has become a valuable tool in epidemiological studies of alcohol and drug use. Oral fluid reflects better than urine whether a subject has recently used alcohol or drugs and reflects whether or not the substance of interest is present in the blood. For most drugs the concentration in oral fluid cannot be used to accurately estimate the drug concentration in blood for an individual because of large inter-individual variations in oral fluid to blood (OF/B) concentration ratios [1] ; the relationship is merely semiquantitative. However, in a population of drug users, the distribution of drug concentrations in oral fluid and the average and median drug concentrations in oral fluid is related to the distribution of drug concentrations in blood samples from that population, including the average and median concentrations. Individual variations will affect the drug concentration distribution and average less if the population size is large, similar to the fact that the standard error of a mean is small if the sample size is large.
In some cross-sectional studies of drug use, participants were asked to provide a blood sample, and those who objected were asked to provide a sample of oral fluid [2, 3] . In those studies, analytical results from blood and oral fluid samples were used to calculate the overall prevalence of drug use. In that type of studies, useful calculations of prevalence can only be performed if equivalent drug cutoff concentrations are used for blood and oral fluid.
Case-control studies should ideally be performed by using the same type of biological specimen for both cases and control. However, that may be difficult. In some studies, for example the Immortal [4] and DRUID [3] studies of alcohol, drugs and traffic accidents, samples of blood were collected from cases and oral fluid from controls. Equivalent cutoff thresholds must also be used in that type of studies to compare prevalence among cases and controls and to obtain sound estimations of odds ratio for involvement in traffic accidents after having used different types of drugs.
The use of equivalent cutoff concentrations in blood and oral fluid implies that both specimens would, on average, be positive for a drug for the same length of time after intake.
In addition, the prevalence of positive drug findings (i.e., concentration above the cutoff threshold) in samples of oral fluid would reflect the prevalence of positive drug findings in blood samples.
We have previously found that equivalent cutoff concentrations in blood and oral fluid for amphetamine and THC may be roughly estimated by multiplying the cutoff concentration in blood with the mean or median OF/B ratio or with the slope of a linear regression curve (regression coefficient) [5] . A second possibility was to use a mathematical simulation [5] , which is a more challenging procedure. However, accurate estimations were not observed for drug prevalences in blood below 15%.
The aim of this investigation was to describe and validate a novel method for estimating equivalent drug cutoff concentrations in blood and oral fluid which is expected to be more accurate than using the mean or median OF/B ratio or regression coefficient between concentrations in OF and blood. Populations of tetrahydrocannabinol or amphetamine users were used for this purpose.
Materials and Methods

Study population
The Rosita-2 Project [6] included drivers who were apprehended by police in seven countries suspected for driving under the influence of drugs. Samples of oral fluid were collected by using the Intercept Oral Specimen Collection Device (OraSure Technologies, Bethlehem PA, USA), and whole blood samples were also obtained. Samples of whole blood and oral fluid were analysed by chromatographic-mass spectrometric methods. In some countries, the drug concentrations in undiluted oral fluid were calculated by using the average dilution factor, in other countries by determining the dilution for each single sample by weighing the samples. Analytical findings have been presented elsewhere [1, 6 ].
All drivers who tested positive for THC or amphetamine in samples of oral fluid, and from whom results for analysis of THC and amphetamine in blood were available, were selected for this study.
Analytical method
Samples of oral fluid were analysed by different laboratories using different methods based on gas chromatography or high-performance liquid chromatography, both with mass spectrometric detection. References to the employed methods have been presented elsewhere To determine how well the formulae fitted the original data, the prevalences of drug concentrations above estimated cutoff thresholds in oral fluid were compared with the prevalences of drug concentrations above the corresponding cutoff thresholds in blood.
Prevalence regression
To determine how many samples of oral fluid and blood was needed to obtain accurate and precise determinations of equivalent cutoff thresholds, 20, 40, 60 and 80 paired samples were e populations of amphetamine and cannabis users, regression formulae were determined, and cutoff concentrations in oral fluid that were equivalent to the chosen cutoff concentrations in blood were calculated. Estimated prevalence was compared with actual prevalence in blood.
Inaccuracy and precision within ±25% was regarded as acceptable.
Results
Tetrahydrocannabinol (THC) was found in samples of oral fluid from 311 individuals.
Individual concentration data for THC in oral fluid are plotted against the corresponding concentrations in oral fluid versus blood was 0.46, RThe median THC concentrations in oral fluid among subjects with blood THC concentrations in the ranges <5, 5-9, 10-14 and 15-22 ng/ml were 17, 96, 158 and 275 ng/ml, respectively.
The concentrations in oral fluid corresponding to the 10 th percentile, the 20 th percentile, and so forth until the 90 th percentile are plotted against the concentrations of the corresponding percentiles in blood in Figure 1 (bottom).
The best fitting regression curves were obtained using either a quadratic curve passing through the origin or a power curve. The formula for the quadratic curve function was Table 1 and show that the power and quadratic regression curves matched the prevalence in blood for the studied populations very well; for THC the quadratic function seemed to be slightly better.
<Table 1 about here>
A study was performed to determine the number of individual data required to obtain regression formulae which gave precision and accuracy within ±25%, which was regarded as acceptable. From the original populations of amphetamine and THC users, 20, 40, 60 and 80 subjects were selected at random, and the drug concentrations in oral fluid and blood were used to calculate quadratic and power regression formulae. Those formulae were used to estimated prevalence based on data for oral fluid and compared with actual data for blood for the complete populations. Results are presented in Table 2 . When reducing the number of samples from 311 for THC or 197 for amphetamine to 20-80, power functions gave better correlation than quadratic functions. However, data from 60 and 80 persons were needed to obtain reliable regression formulae for amphetamine and THC, respectively. The accuracy and precision were then equal to or better than ±25% for estimating prevalence above cutoff concentrations in blood equal to or below 1000 ng/ml for amphetamine and 10 ng/ml for THC, when using data from 80 persons the accuracy and precision was better than ±20% for both substances. <Table 2 about here>
Discussion
There is a correlation between drug concentration in oral fluid and blood from drugs of abuse [1] . This correlation implies that there also will be a correlation between the drug prevalence in oral fluid samples and the prevalence in blood samples from a selected population.
THC and amphetamine were chosen as drugs to be studied only because of large numbers of paired data on drug concentrations in oral fluid and blood were available from the Rosita-2 study. THC and amphetamine may not be the ideal model substances because of very large variations in OF/B ratios between individuals.
The concentrations of most drugs in oral fluid are results of transfer from blood which is affected by protein binding, oral fluid pH, salivary flow rate, and other factors [7] . For THC the situation is be more complex. The transfer of THC from blood to oral fluid seems to be low, so the observed THC is mainly due to contamination of the oral cavity after cannabis smoking [9] . The THC concentration in oral fluid is therefore correlated with the smoked dose and time after smoking and thus with the blood THC concentration through an indirect mechanism.
Amphetamine has a pKa close to the pH of oral fluid. Individual variations in oral fluid pH affect very much the equilibrium ratio between amphetamine in blood and oral fluid, therefore the variation in OF/B ratios is large for amphetamine compared to many other drugs.
It is likely that drugs with less variations in OF/B ratios, e.g. some benzodiazepines, will provide regression formulae that are more robust and less dependent on the study population than THC and amphetamine. It is also expected that those drugs might not require as many as 80 paired oral fluid and blood samples to enable the calculation of a good regression curve formula.
Quadratic regression models (y = ax 2 + bx + c) or power models x ) fitted the regression data for concentration percentiles of THC and amphetamine in oral fluid versus blood better than linear models. We have previously tested the accuracy and precision of linear models using the regression coefficient (slope of the linear regression line), average and median OF/B ratio, and found that those procedures gave acceptable accuracy only for limited concentration ranges [5] .
A comparison of the quadratic and power regression model with those obtained using the average and median OF/B ratios is presented in Figure 3 . When plotting the regression curves for models using average or median OF/B ratios, linear curves that pass through the origin are obtained, and the slopes of the curves correspond to the average or median OF/B ratios, respectively. As an example, the figure illustrates that for amphetamine, cutoff concentrations in the range from about 50 to 450 ng/ml in blood are approximately equivalent to cutoff concentrations in oral fluid equal to the cutoff concentration in blood multiplied with the median OF/B ratio. However, for a cutoff concentration in blood of about 800 ng/ml, multiplying with the average OF/B ratio would give a better approximation for the equivalent cutoff concentration in oral fluid. This is in accordance with our earlier findings [5] . OF/B ratios when using the average OF/B ratio or the OF/B regression coefficient, the accuracy was not improved [5] , and increasing the number of OF/B ratios from 20 to 50 using Monte Carlo simulation did not increase the precision (Gjerde and Verstraete, unpublished observations). Thus, the method presented in this report has a potential of giving better accuracy and precision than our previous methods, but if limited OF/B data are available, our previously proposed methods should be used [5] .
This study has some important limitations. The method for sampling oral fluid may affect the drug concentrations found [10] and thus also the regression formulae. The concentration might also depend on the population, e.g. heavy amphetamine users may have amphetamineinduced xerostomia (lack of saliva), which may affect the equilibrium between amphetamine concentrations in oral fluid and blood. For THC, the average and median OF/B ratios shortly after cannabis smoking might differ from those observed many hours later. Therefore, the aim of this report is not to present exact and robust regression formulae that can be used on any other population, but to present a method for determining those formulae for other study populations.
The regression formulae presented in this report are valid for the studied populations of suspected drugged drivers found to be positive for THC or amphetamine, and probably also for similar populations if the sampling of oral fluid is performed with the same type of device.
When determining a regression formula to estimate equivalent cutoff concentrations in oral fluid and blood, we recommend that the formula should be determined by using oral fluid samples that are collected from a selection of the population study participants using the same type of collection device as in the population study itself or from a similar population.
The data material used in our study was based on samples of oral fluid and blood collected in several countries and analysed by several laboratories using different analytical methods. This may have introduced some inter-laboratory variation in analytical results [1] . There was in some cases a time lapse of more than 30 minutes between sampling of oral fluid and blood, and when calculating the drug concentrations in native oral fluid, some laboratories used the mean collected volume for the calculation of dilution instead of individual values [1] . These issues introduced some additional variation in the results.
Conclusion
The results indicate that prevalence regression may be used to estimate equivalent cutoff thresholds in oral fluid and blood for drug prevalence studies and case-controls studies.
However, a large number of paired drug concentrations in oral fluid and blood is needed, preferably about 80 for THC and amphetamine. 
